- Home
- YIBO vs ACRV Comparison
YIBO vs ACRV Comparison
Compare YIBO & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YIBO
- ACRV
- Stock Information
- Founded
- YIBO 2011
- ACRV 2018
- Country
- YIBO China
- ACRV United States
- Employees
- YIBO N/A
- ACRV N/A
- Industry
- YIBO
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- YIBO
- ACRV Health Care
- Exchange
- YIBO NYSE
- ACRV Nasdaq
- Market Cap
- YIBO 71.7M
- ACRV 59.9M
- IPO Year
- YIBO 2024
- ACRV 2022
- Fundamental
- Price
- YIBO $1.23
- ACRV $1.16
- Analyst Decision
- YIBO
- ACRV Strong Buy
- Analyst Count
- YIBO 0
- ACRV 5
- Target Price
- YIBO N/A
- ACRV $19.75
- AVG Volume (30 Days)
- YIBO 18.5K
- ACRV 1.3M
- Earning Date
- YIBO 05-23-2025
- ACRV 05-20-2025
- Dividend Yield
- YIBO N/A
- ACRV N/A
- EPS Growth
- YIBO N/A
- ACRV N/A
- EPS
- YIBO 0.13
- ACRV N/A
- Revenue
- YIBO $149,828,000.00
- ACRV N/A
- Revenue This Year
- YIBO N/A
- ACRV N/A
- Revenue Next Year
- YIBO N/A
- ACRV N/A
- P/E Ratio
- YIBO $9.15
- ACRV N/A
- Revenue Growth
- YIBO N/A
- ACRV N/A
- 52 Week Low
- YIBO $0.95
- ACRV $1.30
- 52 Week High
- YIBO $17.47
- ACRV $10.29
- Technical
- Relative Strength Index (RSI)
- YIBO 49.79
- ACRV 28.93
- Support Level
- YIBO $1.18
- ACRV $1.32
- Resistance Level
- YIBO $1.28
- ACRV $1.50
- Average True Range (ATR)
- YIBO 0.09
- ACRV 0.17
- MACD
- YIBO 0.03
- ACRV 0.06
- Stochastic Oscillator
- YIBO 49.28
- ACRV 1.55
About YIBO PLANET IMAGE INTERNATIONAL LIMITED
Planet Image International Ltd is engaged in manufacturing and selling compatible toner cartridges. It develops and manufactures toner cartridges that are compatible with, and can be used in, a wide range of commonly available models of laser printers from different manufacturers, or compatible toner cartridges, on a white-label or third-party brand basis or under its self-owned brands. The company also sells its branded products through online sales channels under four brands, TrueImage, CoolToner, AZtech, and Toner Bank. The company operates in North America, Europe, and Other countries.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.